St. Jude Medical, Inc. (STJ) Tops Q3 EPS by 2c; Guides Q4 Below the Street
Tweet
Share
E-mailGet Alerts STJ Hot Sheet
Join SI Premium – FREE
St. Jude Medical, Inc. (NYSE: STJ) reported Q3 EPS of $0.78, $0.02 better than the analyst estimate of $0.76. Revenue for the quarter came in at $1.38 billion versus the consensus estimate of $1.37 billion.
St. Jude Medical, Inc. sees Q4 2011 EPS of $0.83-$0.85, versus the consensus of $0.86.
St. Jude Medical, Inc. sees Q4 2011 EPS of $0.83-$0.85, versus the consensus of $0.86.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Applied Materials (AMAT) Tops Q3 EPS by 10c, Offers Guidance
- Coherent, Inc. (COHR) Tops Q4 EPS by 12c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
